Patient considerations in the management of toe onychomycosis – Role of efinaconazole

Charlotte E. LaSenna, Antonella Tosti

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Onychomycosis is a difficult diagnosis to manage and treatment is sometimes avoided, as this diagnosis is often wrongly perceived as a cosmetic problem. However, onychomycosis has a negative impact on patients’ quality of life, affecting social interaction, psychological well-being, and physical activities. Onychomycosis is also a risk factor for patients with diabetes, with proven increased rates of cellulitis, gangrene, and foot ulcers. Treatments are only mild to moderately effective, and rates of relapse and reinfection are high. Oral treatments require laboratory monitoring due to risk of hepatotoxicity and may be contraindicated in some patients due to risk of drug–drug interactions. Topical treatments require prolonged application and are not very effective. Efinaconazole 10% solution is a new topical triazole treatment for mild to moderate distal subungual onychomycosis, with good efficacy and without the need for debridement of nails. In onychomycosis of the toenails, efinaconazole 10% solution is documented to have a statistically significant, positive impact on patient satisfaction and quality of life.

Original languageEnglish (US)
Pages (from-to)887-891
Number of pages5
JournalPatient Preference and Adherence
StatePublished - Jun 30 2015


  • Antifungal
  • Dermatophyte
  • Fungus
  • Nail
  • Quality of life
  • Treatment

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Social Sciences (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Health Policy


Dive into the research topics of 'Patient considerations in the management of toe onychomycosis – Role of efinaconazole'. Together they form a unique fingerprint.

Cite this